Toll‐like receptor 8 is a therapeutic target in rheumatoid arthritis

Key Points

• Investigate the role of toll-like receptor 8 in the development of rheumatoid arthritis and assess its potential as a treatment target.
• Analyzed the role of TLR8 in rheumatoid arthritis pathogenesis.
• Investigated therapeutic implications of targeting TLR8 in treatment strategies.
• Identified TLR8's significant role in the progression of rheumatoid arthritis.
• Suggest that targeting TLR8 may lead to new treatment options for managing the disease.

Abstract